On 26th November, Asian Star, ASAlaser’s partner in South Korea, celebrated the milestone marked by the sale of 100 Hilterapia® Hiro 3.0 systems in South Korea: the occasion was provided by the one-day event entirely dedicated to our laser which took place at the Best Western Gang Nam Hotel in Seoul.
Titled "Hilterapia Symposium 2016", the event brought together doctors and professionals with the aim of evaluating the results obtained with Hilterapia® in various critical conditions and to discuss how to optimise these through specific protocols. Two doctors took the floor, Dr Heon Sang Lee of the Grace Orthopedic Clinic who presented a treatment comparison study of tennis elbow with and without Hilterapia® in combination with other therapeutic techniques such as shock-waves, and Dr Tae Yeon Rhie of the Nalgae Hospital, a facility which specialises in the treatment of joint problems, who presented a study on shoulder pain treatments. The two speeches were respectively entitled: "Diseases of the upper limbs: neck (cervical region), shoulder, elbow, wrist, hand" and “Diseases of the lower limbs and dorsal-lumbar spine".
The speech by Lucio Zaghetto, Scientific & Educational Director of ASAlaser, who presented some clinical cases related to the treatment of severe and degenerative conditions such as knee osteoarthritis and injuries to tendons and ligaments, completed the overview concerning Hilterapia® applications.
The participants showed positive interest and at the end of the speech asked many questions concerning treatment procedures and the combination and comparison of Hilterapia® with other instrumental therapies.
"We are very pleased with the outcome of the symposium - said Mr Kwon, General Manager of Asian Star - despite the adverse weather conditions we counted around a hundred participants who shared this important milestone with us, thereby confirming the positive growth trend obtained during recent years".
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.